Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
September 11, 2002
INTERNATIONAL IMMUNIZATION NEWS
"PowderJect Begins Phase I Trials of Powder Flu Vaccine" AFX-Europe (www.afxpress.com/corporate/AFX-Europe.htm) (09/10/02)
The Fluvirin powdered flu vaccine developed by PowderJect Pharmaceuticals of the United Kingdom has entered into Phase I clinical trials, according to PowderJect. The drug is delivered in a powdered formulation through the skin, shot through with no injection using a one-time disposable syringe. PowderJect will compare the formulation to its own Fluvirin, an approved liquid flu vaccine that is delivered by injection. The powdered drug can now be produced at PowderJect's Liverpool plant; until recently, only the firm's Madison, Wis., facility could make the drug.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.